International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings

BACKGROUND: Psoriatic arthritis (PsA) is a challenging heterogeneous disease. The European League Against Rheumatism (EULAR) and the Group for Research and Assessment of Psoriasis and PsA (GRAPPA) last published their respective recommendations for the management of PsA in 2015. However, these guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmamoun, M., Eraso, M., Anderson, M., Maharaj, A., Coates, L., Chandran, Vinod, Abogamal, A., Adebajo, A. O., Ajibade, A., Ayanlowo, O., Azevedo, V., Bautista-Molano, W., Carneiro, S., Goldenstein-Schainberg, C., Hernandez-Velasco, F., Ima-Edomwonyi, U., Lima, A., Medina-Rosas, J., Mody, G. M., Narang, T., Ortega-Loayza, A. G., Ranza, R., Sharma, A., Toloza, S., Vega-Espinoza, L., Vega-Hinojosa, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237392/
https://www.ncbi.nlm.nih.gov/pubmed/31950441
http://dx.doi.org/10.1007/s10067-020-04934-7
Descripción
Sumario:BACKGROUND: Psoriatic arthritis (PsA) is a challenging heterogeneous disease. The European League Against Rheumatism (EULAR) and the Group for Research and Assessment of Psoriasis and PsA (GRAPPA) last published their respective recommendations for the management of PsA in 2015. However, these guidelines are primarily based on studies conducted in resource replete countries and may not be applicable in countries in the Americas (except Canada and USA) and Africa. We sought to adapt the existing recommendations for these regions under the auspices of the International League of Associations for Rheumatology (ILAR). PROCESS: The ADAPTE Collaboration (2009) process for guideline adaptation was followed to adapt the EULAR and GRAPPA PsA treatment recommendations for the Americas and Africa. The process was conducted in three recommended phases: set-up phase; adaptation phase (defining health questions, assessing source recommendations, drafting report), and finalization phase (external review, aftercare planning, and final production). RESULT: ILAR recommendations have been derived principally by adapting the GRAPPA recommendations, additionally, EULAR recommendations where appropriate and supplemented by expert opinion and literature from these regions. A paucity of data relevant to resource-poor settings was found in PsA management literature. CONCLUSION: The ILAR Treatment Recommendations for PsA intends to serve as reference for the management of PsA in the Americas and Africa. This paper illustrates the experience of an international working group in adapting existing recommendations to a resource-poor setting. It highlights the need to conduct research on the management of PsA in these regions as data are currently lacking. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10067-020-04934-7) contains supplementary material, which is available to authorized users.

Ejemplares similares